Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis

To study the safety profile and characterize the immunologic effects of high- vs low-dose cholecalciferol supplementation in patients with multiple sclerosis (MS). In this double-blind, single-center randomized pilot study, 40 patients with relapsing-remitting MS were randomized to receive 10,400 IU...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Neurology Ročník 86; číslo 4; s. 382
Hlavní autoři:	Sotirchos, Elias S, Bhargava, Pavan, Eckstein, Christopher, Van Haren, Keith, Baynes, Moira, Ntranos, Achilles, Gocke, Anne, Steinman, Lawrence, Mowry, Ellen M, Calabresi, Peter A
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 26.01.2016
Témata:	Adult CD4 Lymphocyte Count CD4-Positive T-Lymphocytes - metabolism Cholecalciferol - administration & dosage Cholecalciferol - adverse effects Cholecalciferol - pharmacology Dietary Supplements Double-Blind Method Female Humans Immunologic Factors - administration & dosage Immunologic Factors - adverse effects Immunologic Factors - pharmacology Interleukin-17 - metabolism Male Middle Aged Multiple Sclerosis, Relapsing-Remitting - drug therapy Multiple Sclerosis, Relapsing-Remitting - immunology Pilot Projects Treatment Outcome Vitamin D - analogs & derivatives Vitamin D - blood
ISSN:	1526-632X, 1526-632X
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!